Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability
Kyung‐Ho Jung(Samsung (South Korea)), Kyung‐Han Lee(Samsung Medical Center)
Cited by 15
Related Papers
<sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
|Journal of Nuclear Medicine|2020|38
EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling
|PLoS ONE|2019|31